SARS-CoV-2 viral load in the upper respiratory tract of children and adults with early acute COVID-19
Stéphanie Baggio(University of Bern), Isabella Eckerle(University of Geneva), Arnaud G. L’Huillier, Natasha Loevy(University of Geneva), Frédérique Jacquérioz(Apple (Israel)), Marie Rohr(Service de Santé de la Jeunesse), Laurent Kaiser(University Hospital of Geneva), Angela Huttner(University Hospital of Geneva), Géraldine Blanchard‐Rohner(University of Geneva), Mathilde Bellon(University Hospital of Geneva), Noémie Wagner(University Hospital of Geneva), Sabine Yerly(Unknown)
Cited by 54
Related Papers
Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum
|Antimicrobial Resistance and Infection Control|2013|454
Clinical Presentation of Patients with Ebola Virus Disease in Conakry, Guinea
|New England Journal of Medicine|2014|389
How to use biomarkers of infection or sepsis at the bedside: guide to clinicians
|Intensive Care Medicine|2023|293
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial
|The Lancet Infectious Diseases|2015|278
Oral amoxicillin and amoxicillin–clavulanic acid: properties, indications and usage
|Clinical Microbiology and Infection|2019|263